Alex Zhavoronkov - CEO Insilico Medicine

<p>In this episode of Life Science Success my Guest is Alex Zhavoronkov.  Alex is the CEO Insilico Medicine an AI-powered drug discovery company.</p> <ul> <li>Insilico Medicine has progressed three internally-derived assets into human clinical trials.</li> </ul> <ul> <li>Insilico Medicine has discovered over 30 other programs in different stages.</li> <li>Insilico Medicine incorporates three engines in their platform: biology, chemistry, and clinical.</li> <li>They generate normal molecules with desired properties using 42 generative engines.</li> <li>They have a system that predicts clinical trials outcomes.</li> <li>Insilico Medicine’s main strategy is partnering with pharma companies at the preclinical candidate stage.</li> <li>They value patient first, relentless innovation, and transparency and integrity.</li> <li>Alex's biggest concern is human tendency to prioritize unimportant things over important ones.</li> <li>Alex is excited about large language models, multimodal generative AI, robotics, and quantum computing.</li> </ul>